EnaBio
Develops high-performance modified biomaterials for FDM 3D printing, including PLA, PETG, and PA-based filaments with enhanced toughness, transparency, and fiber reinforcement.
- CEO / Founder
- Zhou Zhen
- Team Size
- 11-50
- Stage
- Active
- Total Funding
- $1.4M
- Latest Round
- Angel
- Key Investors
- Linear Capital; Bluepha
Technology & Products
Key Products
High-speed FDM filaments; High-toughness materials; Transparent toughness filaments; Matte finish materials; Glass fiber reinforced filaments; Carbon fiber reinforced filaments; PLA-based materials; PETG-based materials; PA-based materials
Technological Advantage
Proprietary material formulations for FDM 3D printing that offer enhanced characteristics (toughness, transparency, reinforcement) compared to standard filaments, targeting niche industrial applications.
Differentiation
Value Proposition
Provides customized, high-performance FDM materials that improve printing reliability and part properties for demanding applications, reducing material waste and enabling new design possibilities.
How They Differentiate
Specializes in modified biomaterials for FDM 3D printing with a focus on high-performance characteristics (toughness, transparency, fiber reinforcement), whereas many competitors offer standard PLA/PETG filaments without such enhancements.
Market & Competition
Target Customers
Industrial 3D printing users, manufacturers requiring specialized polymer materials
Industry Verticals
3D Printing; Additive Manufacturing; Industrial Manufacturing
Competitors
eSUN (易生) and other high-performance PLA/PETG FDM filament & bio-material modifiers; polymer AM materials players (not metal powder suppliers)
Growth & Milestones
Growth Metrics
Expanding product line with high-performance FDM materials; Participated in TCT Asia 2026 exhibition
Major Milestones
Founded in August 2022; Launched series of high-performance FDM 3D printing materials; Participated in TCT Asia 2026 exhibition